Universal-Beteiligungs- und Servicegesellschaft
VKTX icon

Universal-Beteiligungs- und Servicegesellschaft’s Viking Therapeutics VKTX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$247K Sell
7,597
-19,144
-72% -$615K ﹤0.01% 1926
2025
Q4 		$941K Buy
+26,741
New +$947K ﹤0.01% 1512
2025
Q3 		– Sell
-8,427
Closed -$223K – 2168
2025
Q2 		$223K Sell
8,427
-92
-1% -$2.42K ﹤0.01% 1910
2025
Q1 		$206K Buy
+8,519
New +$269K ﹤0.01% 1883

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's VKTX Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Viking Therapeutics (VKTX) stake by 72% in Q1 2026, selling an estimated $615K and leaving 7,597 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in VKTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $941K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 7,597 shares of Viking Therapeutics worth $247K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 19,144 Viking Therapeutics shares in Q1 2026, an estimated $615K.
  • Viking Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1926 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Viking Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Viking Therapeutics position peaked at $941K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.